← Every company
Cogent Biosciences Inc Executive Compensation
What Cogent Biosciences Inc's board awarded its chief executive, and what the same award was worth once the share price had moved. Companies have had to disclose both since 2023, and they routinely differ by several times over.
COGT on carbonthat →Latest year
2025
4 years disclosed
Awarded that year
$27.8M
Actually paid
$116.8M
after revaluation
Across every year
$45M
$138.3M actually paid
Year by year
Newest first. A negative figure means the award lost more than its whole value over the year.
| Year | Awarded | Actually paid |
|---|---|---|
| 20254.2×$100 → $414 | $27.8M | $116.8M |
| 20242.4×$100 → $91 | $4.9M | $11.9M |
| 2023-0.0×$100 → $69 | $7.9M | -$201.5K |
| 20222.2×$100 → $135 | $4.4M | $9.8M |
Source: pay-versus-performance disclosures, read from SEC XBRL company facts. "Compensation actually paid" is a revaluation of awards that may never vest, not cash received — a board that awards shares and watches them halve discloses the second, smaller figure, and that is the disclosure working rather than a pay cut. Only the years a company tagged where the SEC's data can reach them appear here.
More on COGT
Company overviewEverything on COGT in one place, with the price.SEC filingsWhat COGT's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat COGT's own officers and directors buy and sell.Who owns itEvery manager reporting a position in COGT.Funds holding itWhich funds and ETFs hold COGT, and how big a bet.PatentsWhat COGT is filing at the patent office.